Sign In
Buy MIRM
$105.95
-6.64 (-5.90%)
At Close: Jul 31, 2026
Mirum Stock Rises 7% in a Week: Here's What You Should Know
12:10pm, Friday, 16'th Jan 2026
MIRM shares rise this week on strong preliminary 2025 sales, upbeat 2026 outlook, key pipeline goals and business updates.
Mirum Pharmaceuticals, Inc. (MIRM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
05:16pm, Wednesday, 14'th Jan 2026
Mirum Pharmaceuticals, Inc. (MIRM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
3 Top Growth Stocks to Buy in the First Half of 2026
04:44am, Tuesday, 13'th Jan 2026
Meta Platforms is an advertising juggernaut with tremendous growth potential in the AI glasses market. Micron Technology is a steal of a deal among AI stocks.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:30pm, Monday, 12'th Jan 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026
11:00am, Monday, 12'th Jan 2026
A director at Mirum Pharmaceuticals sold 5,000 shares of the company for $400,000 on Dec. 22. The entire transaction was direct, involving the exercise of vested stock options, immediately sold as sha
Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum
08:30am, Monday, 12'th Jan 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum.
ESCONDIDO, Calif.--(BUSINESS WIRE)--Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its l
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
04:01pm, Wednesday, 07'th Jan 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference.
5 Predictions for the Stock Market in 2026 -- and Which Stocks Will Soar the Most If They're Right
03:45am, Sunday, 04'th Jan 2026
Not all of these predictions may come true. But at least a few of them will likely do so.
Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now
02:47am, Tuesday, 30'th Dec 2025
Fox is Newsmax's primary rival and should remain much bigger than Newsmax by the end of the decade. Mirum Pharmaceuticals is a small drugmaker that's poised to deliver tremendous growth.
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line
03:11pm, Sunday, 28'th Dec 2025
Boston-based Eventide Asset Management sold 114,922 shares of Mirum Pharmaceuticals during the third quarter. Despite the sale, the overall value of the position increased by about $50.70 million from
This Biotech Name Outperforms 93% Of Stocks, And It's In A Buy Zone
01:51pm, Tuesday, 23'rd Dec 2025
This biotech stock reached an all-time high and is in a buy zone. The company makes drugs for rare diseases.
Mirum: Maintaining Buy Rating On VOLIXIBAT PSC Treatment Data Q2 2026
03:31pm, Monday, 22'nd Dec 2025
Mirum Pharmaceuticals, Inc. retains a Buy rating, supported by positive interim analyses for VOLIXIBAT in both PBC [VANTAGE] and PSC [VISTAS] phase 2b trials. Key catalysts include VISTAS topline data
Squarepoint Ops LLC Decreases Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM
05:16am, Monday, 22'nd Dec 2025
Squarepoint Ops LLC lowered its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) by 47.0% during the second quarter, according to the company in its most recent Form 13F filing with the S
Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX
08:30am, Friday, 19'th Dec 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX.
